Reis Costa D, Winge-Main AK, Skog A, Tsuruda KM, Robsahm TE, Kulle Andreassen B (2024)
From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway
Acta Oncol, 63, 965-973
DOI 10.2340/1651-226X.2024.41266, PubMed 39690735

Farooqi SJ, Zhao Z, Öjlert ÅK, Thunold S, Juul HV, Bjaanæs MM, Horndalsveen H, Nymoen HMG, Helland Å, Haakensen VD (2024)
Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
Front Immunol, 15, 1480183
DOI 10.3389/fimmu.2024.1480183, PubMed 39687621

Safont MM, Leitch C, Popa M, Gjerstad ME, Caulier B, Inderberg EM, Wälchli S, Gelebart P, Cormack EM (2024)
Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapy
STAR Protoc, 5 (4), 103522
DOI 10.1016/j.xpro.2024.103522, PubMed 39673705